Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07313774) titled 'A Randomized, Phase 3 Multicenter Clinical Trial to Confirm the Clinical Efficacy and Evaluate the Safety of Linaprazan Glurate Compared to Lansoprazole in Participants With Healed Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD)' on Dec. 19, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Cinclus Pharma Holding AB
Condition:
GERD (Gastroesophageal Reflux Disease)
Intervention:
Drug: Linaprazan glurate - H...